Folic Acid Supplementation in Pregnant Women: Dose Response

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2017

Conditions
Pregnancy
Interventions
DIETARY_SUPPLEMENT

Folic acid, 400 mcg/day

The supplement regime for this arm will consist of (1) a women's multivitamin/ multimineral (MVM) supplement containing 400 mcg folic acid, (2) a capsule containing 200 mg DHA and (3) a capsule formulated to contain 10 mg iron (which represents the difference in the amount of iron in the women's MVM formulation and that in prenatal MVM supplements).

DIETARY_SUPPLEMENT

Folic acid 800 mcg/day

The supplement regime for this arm will consist of (1) a women's multivitamin/ multimineral (MVM) supplement containing 400 mcg folic acid, (2) a capsule containing 200 mg DHA and (3) a capsule formulated to contain 10 mg iron (which represents the difference in the amount of iron in the women's MVM formulation and that in prenatal MVM supplements) and 400 mcg folic acid.

Trial Locations (1)

30606

Athens Regional Medical Center Midwifery Practice, Athens

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Florida

OTHER

collaborator

Emory University

OTHER

collaborator

Cornell University

OTHER

lead

University of Georgia

OTHER

NCT02124642 - Folic Acid Supplementation in Pregnant Women: Dose Response | Biotech Hunter | Biotech Hunter